Dybkowska K
Z Zakładu Anestezjologii i Intensywnej Opieki Medycznej Pomorskiej Akademii Medycznej w Szczecinie, Szczecin.
Ann Acad Med Stetin. 1997;43:211-24.
The aim of the work was to check if cerebrospinal fluid drainage performed under general anaesthesia altered in time the permeability of the blood/cerebrospinal fluid barrier (BCSFB), the part of blood-brain barrier. Twelve adult Chinchilla rabbits were included into the study. The animals were divided into 2 groups: control and investigated. The cerebrospinal fluid drainage was performed in animals from the studied group. Gentamycin was applied as the marker of tightness of BCSFB; under normal circumstances BCSFB prevented or limited the passage of gentamycin to the cerebrospinal fluid after intravenous administration. Heart rate (HR), arterial blood pressure (SAP, DAP, MAP), central venous pressure (CVP), blood-gas analysis (BGA), end-expiratory CO2 pressure (et CO2), hemoglobin, hematocrit, intracranial pressure (ICP) and cerebral perfusion pressure (CPP) were recorded. General anaesthesia was performed under circumstances that excluded the influence of any additional factor on the permeability of the BCSFB and haemodynamic, haematologic and gasometric parameters were stable in all animals. The influence of the cerebrospinal fluid drainage on the permeability of the BCSFB was evaluated using gentamycin concentration levels in blood and cerebrospinal fluid. Mean haemodynamic, haematologic and gasometric parameter values showed no within-group and between-group differences. In the investigated group the cerebrospinal fluid drainage was followed by a decrease in intracranial pressure (Tab. 1, Fig 1.) without changes in cerebral perfusion pressure (Tab. 2, Fig. 2). No significant changes in gentamycin permeability indexes were stated (Tab. 3, Fig. 3). Cerebrospinal fluid drainage performed under general anaesthesia caused no increase of the permeability of the BCSFB. A decrease of the intracranial pressure without changes of the cerebral perfusion pressure followed the cerebrospinal fluid drainage.
这项工作的目的是检查在全身麻醉下进行的脑脊液引流是否会随时间改变血脑屏障(BCSFB)(血脑屏障的一部分)的通透性。12只成年龙猫兔被纳入研究。动物被分为两组:对照组和研究组。对研究组的动物进行脑脊液引流。庆大霉素被用作BCSFB紧密性的标志物;在正常情况下,BCSFB可防止或限制庆大霉素在静脉给药后进入脑脊液。记录心率(HR)、动脉血压(收缩压、舒张压、平均动脉压)、中心静脉压(CVP)、血气分析(BGA)、呼气末二氧化碳分压(et CO2)、血红蛋白、血细胞比容、颅内压(ICP)和脑灌注压(CPP)。在排除任何其他因素对BCSFB通透性的影响且所有动物的血流动力学、血液学和气体测量参数稳定的情况下进行全身麻醉。使用血液和脑脊液中的庆大霉素浓度水平评估脑脊液引流对BCSFB通透性的影响。平均血流动力学、血液学和气体测量参数值在组内和组间均无差异。在研究组中,脑脊液引流后颅内压降低(表1,图1),而脑灌注压无变化(表2,图2)。庆大霉素通透性指数无显著变化(表3,图3)。全身麻醉下进行的脑脊液引流不会导致BCSFB通透性增加。脑脊液引流后颅内压降低,而脑灌注压无变化。